Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Infectious Diseases

• Publication date

  1990-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INFDIS/162.4.800PMID 2401790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus

  2005cited by this paper
• Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.

  1990cited by this paper
• Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses

  1989cited by this paper
• Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

  1989cited by this paper
• Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies.

  1989cited by this paper
• Cellular Immune Responses in the Murine Lung to Local Immunization with Influenza A Virus Glycoproteins in Micelles and Immunostimulatory Complexes (Iscoms)

  1988cited by this paper
• Protection against lethal influenza with neuraminidase.

  1988cited by this paper
• Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.

  1987cited by this paper
• Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.

  1987cited by this paper
• Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.

  1987cited by this paper
• Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.

  1987cited by this paper
• Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody.

  1986cited by this paper
• Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection.

  1979cited by this paper
• Reinfection with influenza A (H3N2) virus in young children and their families.

  1979cited by this paper
• Influenza as a problem in immunology.

  1978cited by this paper
• Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.

  1977cited by this paper
• Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.

  1976cited by this paper
• The significance of influenza virus neuraminidase in immunity.

  1974cited by this paper
• Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

  1974cited by this paper
• Association of serum anti-neuraminidase antibody with resistance to influenza in man.

  1972cited by this paper
• Studies with avian influenza A viruses: cross protection experiments in chickens.

  1971cited by this paper
• Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.

  1971cited by this paper
• The role of antineuraminidase antibody in immunity to influenza virus infection.

  1969cited by this paper
• Antibody response in man to influenza virus neuraminidase following influenza

  1968cited by this paper
• Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice

  1968cited by this paper
• Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

  1968cited by this paper
• Reduction in Plaque Size and Reduction in Plaque Number as Differing Indices of Influenza Virus-Antibody Reactions

  1966cited by this paper
• COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS.

  1964cited by this paper
• EXPERIMENTAL TRANSMISSION OF INFLUENZA VIRUS INFECTION IN MICE

  1963cited by this paper
• The recurrence of influenza A prime in a boarding school after 2 years.

  1950cited by this paper
• PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A VIRUSES AFTER INCOMPLETE NEUTRALIZATION IN OVO WITH HETEROLOGOUS IMMUNE SERUM

  1950cited by this paper

• Inactivated influenza virions are a flexible vaccine platform for eliciting protective antibody responses against neuraminidase.

  2023cites this paper
• Modernizing the original influenza vaccine to enhance protective antibody responses against neuraminidase antigens

  2023cites this paper
• Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model

  2022cites this paper
• Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

  2020cites this paper
• Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies

  2016cites this paper
• Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity

  2013cites this paper
• Универсальные вакцины против гриппа. Разработки, перспективы использования

  2012cites this paper
• Influenza viral neuraminidase: the forgotten antigen

  2011cites this paper
• Influenza: a unique problem in vaccination

  2010cites this paper
• Mouse Models of Influenza

  2009cites this paper
• Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic.

  2008cites this paper
• Purification of Neuraminidase from Sub Type H5N1 Influenza Virus

  2008cites this paper
• Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines

  2008cites this paper
• Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs.

  2006cites this paper
• Variation in the divalent cation requirements of influenza A virus N1 neuraminidases.

  2006cites this paper
• Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.

  2005cites this paper
• Respiratory Vaccination of Mice Against Influenza Virus: Dissection of T‐ and B‐Cell Priming Functions

  2005cites this paper
• Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

  2005cites this paper
• Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.

  2005cites this paper
• Expression of influenza neuraminidase in CHO-K1 cells

  2004cites this paper
• Variation in the divalent cation requirements of influenza a virus N2 neuraminidases.

  2003cites this paper
• Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.

  2002cites this paper
• Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.

  2000cites this paper
• Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.

  1999cites this paper
• Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.

  1998cites this paper
• Recombinant neuraminidase vaccine protects against lethal influenza.

  1996cites this paper
• Preparation and characterization of a purified influenza virus neuraminidase vaccine.

  1995cites this paper
• Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition.

  1994cites this paper
• Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice.

  1993cites this paper
• Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice.

  1992cites this paper
• Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine.

  1991cites this paper
• Medical Virology 10

  1991cites this paper
• Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection.

  1991cites this paper
• Antibody responses to influenza B viruses in immunologically unprimed children.

  1991cites this paper
• Programmed Antigenic Stimulation — A New Approach to Influenza Vaccination

  1991cites this paper